MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01DD78F8.83A6EB80"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит данный браузер или редактор не поддерживает файлы веб-архива. Скачайте браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"UA90350101_45F1.files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Stohnii, Anzhela UKR</o:Author>
  <o:LastAuthor>bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2026-11-20T11:07:00Z</o:Created>
  <o:LastSaved>2026-11-20T11:07:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>2441</o:Words>
  <o:Characters>13914</o:Characters>
  <o:Lines>115</o:Lines>
  <o:Paragraphs>32</o:Paragraphs>
  <o:CharactersWithSpaces>16323</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"UA90350101_45F1.files/item0001.xml"
target=3D"UA90350101_45F1.files/props002.xml">
<link rel=3DthemeData href=3D"UA90350101_45F1.files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"UA90350101_45F1.files/colorschememap=
ping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"371">
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"macro"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" QFormat=3D"true" Name=3D=
"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Message Header"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" QFormat=3D"true" Name=3D=
"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" QFormat=3D"true" Name=3D=
"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" QFormat=3D"true" Name=3D=
"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Placeholder =
Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 2048 0 0 159 0;}
@font-face
	{font-family:Aptos;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1 3 0 0 415 0;}
@font-face
	{font-family:"Aptos Display";
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1 3 0 0 415 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 1 Знак";
	mso-style-next:Обычный;
	margin-top:18.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h2
	{mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 2 Знак";
	mso-style-next:Обычный;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 3 Знак";
	mso-style-next:Обычный;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 4 Знак";
	mso-style-next:Обычный;
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
h5
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 5 Знак";
	mso-style-next:Обычный;
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h6
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 6 Знак";
	mso-style-next:Обычный;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	color:#595959;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 7 Знак";
	mso-style-next:Обычный;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 8 Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 9 Знак";
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-unhide:no;
	mso-style-link:"Текст примечания Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Верхний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 233.85pt right 467.75pt;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Нижний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 233.85pt right 467.75pt;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
span.MsoCommentReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок Знак";
	mso-style-next:Обычный;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок Знак";
	mso-style-next:Обычный;
	mso-style-type:export-only;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок Знак";
	mso-style-next:Обычный;
	mso-style-type:export-only;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок Знак";
	mso-style-next:Обычный;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Подзаголовок Знак";
	mso-style-next:Обычный;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	letter-spacing:.75pt;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-unhide:no;
	mso-style-link:"Основной текст с отступом 2 Знак";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:none;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-parent:"";
	color:#467886;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	color:#96607D;
	text-decoration:underline;
	text-underline:single;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Цитата 2 Знак";
	mso-style-next:Обычный;
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	color:#404040;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Выделенная цитата Знак";
	mso-style-next:Обычный;
	margin-top:18.0pt;
	margin-right:43.2pt;
	margin-bottom:18.0pt;
	margin-left:43.2pt;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-top-alt:solid #0F4761 .5pt;
	mso-border-bottom-alt:solid #0F4761 .5pt;
	padding:0cm;
	mso-padding-alt:10.0pt 0cm 10.0pt 0cm;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;
	mso-fareast-font-family:Aptos;
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;
	mso-font-kerning:1.0pt;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.MsoIntenseEmphasis
	{mso-style-priority:21;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	color:#0F4761;
	font-style:italic;}
span.MsoIntenseReference
	{mso-style-priority:32;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	font-variant:small-caps;
	color:#0F4761;
	letter-spacing:.25pt;
	font-weight:bold;}
span.1
	{mso-style-name:"Заголовок 1 Знак";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 1";
	mso-ansi-font-size:20.0pt;
	mso-bidi-font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.2
	{mso-style-name:"Заголовок 2 Знак";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 2";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.3
	{mso-style-name:"Заголовок 3 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 3";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.4
	{mso-style-name:"Заголовок 4 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 4";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;
	font-style:italic;}
span.5
	{mso-style-name:"Заголовок 5 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 5";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#0F4761;}
span.6
	{mso-style-name:"Заголовок 6 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 6";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	font-style:italic;}
span.7
	{mso-style-name:"Заголовок 7 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 7";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;}
span.8
	{mso-style-name:"Заголовок 8 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 8";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;
	font-style:italic;}
span.9
	{mso-style-name:"Заголовок 9 Знак";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 9";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#272727;}
span.a
	{mso-style-name:"Заголовок Знак";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Заголовок;
	mso-ansi-font-size:28.0pt;
	mso-bidi-font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Aptos Display";
	mso-bidi-font-family:"Times New Roman";
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
span.a0
	{mso-style-name:"Подзаголовок Знак";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Подзаголовок;
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#595959;
	letter-spacing:.75pt;}
span.20
	{mso-style-name:"Цитата 2 Знак";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Цитата 2";
	color:#404040;
	font-style:italic;}
span.a1
	{mso-style-name:"Выделенная цитата Знак";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Выделенная цитата";
	color:#0F4761;
	font-style:italic;}
span.a2
	{mso-style-name:"Верхний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Верхний колонтитул";}
span.a3
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Нижний колонтитул";}
p.Tblzat-szveg2, li.Tblzat-szveg2, div.Tblzat-szveg2
	{mso-style-name:T\00E1bl\00E1zat-sz\00F6veg2;
	mso-style-unhide:no;
	margin-top:3.0pt;
	margin-right:13.7pt;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:HU;
	mso-fareast-language:HU;}
span.21
	{mso-style-name:"Основной текст с отступом 2 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст с отступом 2";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:0pt;}
span.10
	{mso-style-name:"Незакрита згадка1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	color:#605E5C;
	background:#E1DFDD;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:black;
	mso-ansi-language:HU;
	mso-fareast-language:HU;}
span.a4
	{mso-style-name:"Текст примечания Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст примечания";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-fareast-font-family:Aptos;
	mso-hansi-font-family:Aptos;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("UA90350101_45F1.files/header.htm") fs;
	mso-footnote-continuation-separator:url("UA90350101_45F1.files/header.htm"=
) fcs;
	mso-endnote-separator:url("UA90350101_45F1.files/header.htm") es;
	mso-endnote-continuation-separator:url("UA90350101_45F1.files/header.htm")=
 ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:42.55pt 42.55pt 42.55pt 70.9pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-footer:url("UA90350101_45F1.files/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:-110775542;
	mso-list-type:hybrid;
	mso-list-template-ids:-1 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l0:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1
	{mso-list-id:574166634;
	mso-list-type:hybrid;
	mso-list-template-ids:656281786 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:"Courier New";}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:882328386;
	mso-list-type:hybrid;
	mso-list-template-ids:-1 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l2:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l3
	{mso-list-id:1010529064;
	mso-list-type:hybrid;
	mso-list-template-ids:1059219400 -1440285972 69337091 69337093 69337089 69=
337091 69337093 69337089 69337091 69337093;}
@list l3:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:1119227414;
	mso-list-type:hybrid;
	mso-list-template-ids:-1811229544 1001947674 67436547 67436549 67436545 67=
436547 67436549 67436545 67436547 67436549;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0cm;
	mso-level-number-position:left;
	margin-left:1.0cm;
	text-indent:-1.0cm;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:1174034398;
	mso-list-type:hybrid;
	mso-list-template-ids:1646315742 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l5:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:"Courier New";}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:1250813441;
	mso-list-type:hybrid;
	mso-list-template-ids:-1 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l6:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l6:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l7
	{mso-list-id:1292857827;
	mso-list-type:hybrid;
	mso-list-template-ids:-1165700082 -1440285972 69337091 69337093 69337089 6=
9337091 69337093 69337089 69337091 69337093;}
@list l7:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:1576932132;
	mso-list-type:hybrid;
	mso-list-template-ids:540031192 -781409904 69337091 69337093 69337089 6933=
7091 69337093 69337089 69337091 69337093;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:1674175526;
	mso-list-type:hybrid;
	mso-list-template-ids:-1 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l9:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l9:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l10
	{mso-list-id:1729648157;
	mso-list-type:hybrid;
	mso-list-template-ids:-1007359394 69337089 69337091 69337093 69337089 6933=
7091 69337093 69337089 69337091 69337093;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:1937812050;
	mso-list-type:hybrid;
	mso-list-template-ids:-1 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l11:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l11:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l12
	{mso-list-id:1939555997;
	mso-list-type:hybrid;
	mso-list-template-ids:-1855016104 67436545 67436547 67436549 67436545 6743=
6547 67436549 67436545 67436547 67436549;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0cm;
	mso-level-number-position:left;
	margin-left:1.0cm;
	text-indent:-1.0cm;
	font-family:Symbol;
	color:windowtext;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13
	{mso-list-id:1940020691;
	mso-list-type:hybrid;
	mso-list-template-ids:-1720259584 -1771145052 69337091 69337093 69337089 6=
9337091 69337093 69337089 69337091 69337093;}
@list l13:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:21.75pt;
	text-indent:-18.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:57.75pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:93.75pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:129.75pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:165.75pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:201.75pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:237.75pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:273.75pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:309.75pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:2094545182;
	mso-list-type:hybrid;
	mso-list-template-ids:-1777690562 -781409904 -781409904 69337093 69337089 =
69337091 69337093 69337089 69337091 69337093;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Aptos",sans-serif;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU link=3D"#467886" vlink=3D"#96607D" style=3D'tab-interval:35=
.4pt'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal;mso-outline-level:2'><b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>ІНСТРУКЦІЯ<=
o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>для медичного застосування
лікарського засобу</span></b><span lang=3DUK style=3D'font-size:12.0pt;font=
-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>&nbsp;</span></b><span lang=
=3DUK
style=3D'font-size:13.5pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>ПЕРИТОЛ<sup>®</sup><o:p></o:p=
></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0cm;margin-botto=
m:.0001pt;
text-align:center;line-height:normal'><b><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>(PERITOL<sup>®</sup>)</span><=
/b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>&nbsp;</span></b><span lang=
=3DUK
style=3D'font-size:13.5pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Склад:</span></i></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>діюча речовина: </span></i><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>ципрогептад=
ин
(cyproheptadine);<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>1 таблетка містить ципрогептадину гідрохлориду
сесквігідрату 4,3 мг, що відповідає 4 мг ципрогептадину гідрохлориду;<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>допоміжні речовини</span></i>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>: лактози
моногідрат, крохмаль картопляний, тальк, желатин, магнію стеарат.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:-.05pt;margin-bot=
tom:
0cm;margin-left:14.15pt;margin-bottom:.0001pt;text-align:justify;text-inden=
t:
-14.15pt;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Лікарська форма.&nbsp;</span>=
</b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Таблетки.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Основні фізико-хімічні
властивості:<b> </b></span></i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>білі або сірувато-білі плоскі
круглі таблетки з фаскою, з рискою на одному боці та дугоподібним гравіюван=
ням
«PERITOL» – на другому, без запаху або майже без запаху.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Фармакотерапевтична група.</s=
pan></i></b><b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> </span></b=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Антигістамі=
нні
препарати для системного застосування. Інші антигістамінні препарати для
системного застосування. Ципрогептадин. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Код АТХ<b> </b>R06A X02.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Arial Narrow",sans-serif;mso-fareast-font-family:"Times New Ro=
man";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></i><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Фармакологічні властивості.</=
span></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Фармакодинаміка.</span></i><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадину гідрохлорид – антигістамінний та
антисеротоніновий засіб з антихолінергічною та седативною дією. Ципрогептад=
ин
зв’язується з серотоніновими та <span style=3D'mso-spacerun:yes'>       </s=
pan>Н<sub>1</sub>-гістаміновими
рецепторами, завдяки чому повністю пригнічує зв’язування серотоніну і
гістаміну.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>У дослідах на тваринах ципрогептадин проявляв
антагонізм до таких ефектів серотоніну: бронхоконстрикторного ефекту (у мор=
ських
свинок), вазопресорного ефекту (у собак), спазмогенного ефекту (в ізольован=
ій
матці щурів), розвитку набряків (у щурів), летального ефекту (у мишей, обро=
блених
<i>Haemophilus pertussis</i>). </span><span lang=3DUK style=3D'font-size:12=
.0pt;
font-family:"Times New Roman",serif'>Щодо цих ефектів ципрогептадин був
однаково активним або перевищував активність специфічних антагоністів
серотоніну, таких як 1-бензил-2-метил-5-метокситриптамін (BAS) та
1-бензил-2-метил-5-гідрокситриптамін (BMS). На противагу цьому, специфічні =
антигістамінні
лікарські засоби, навіть високоефективні, </span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>проявляють
незначну або взагалі не проявляють антагоністичної активності щодо серотоні=
ну.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин у дослідах на тваринах зменшував=
 або
блокував такі ефекти гістаміну: </span><span lang=3DUK style=3D'font-size:1=
2.0pt;
font-family:"Times New Roman",serif'>бронхоконстрикторний ефект</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> (у морських
свинок), вазопресорний ефект (у собак), спазмогенний ефект (у ізольованій м=
атці
щурів), розвиток активного та пасивного <span
style=3D'mso-spacerun:yes'> </span>анафілактичного шоку (у морських свинок =
та мишей),
ефект посилення шлункової секреції (у собак, на моделі кишені Гейденгайна).=
 <span
style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Нетипово, що ципрогептадин запобігає розвитку =
анафілактичного
шоку як у морських свинок, так і у мишей. У морських свинок </span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'>ре=
спіраторні</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> прояви
анафілактичного шоку обумовлені вивільненням ендогенного гістаміну та можуть
бути зменшені засобами зі специфічною антигістамінною активністю. Однак у м=
ишей
основну роль відіграє серотонін, а гістамін — другорядну, тому специфічні
антигістамінні засоби лише незначною мірою ефективні у запобіганні
анафілактичним реакціям. Отже, захисний ефект ципрогептадину у мишей зумовл=
ений
його антисеротоніновими властивостями. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин блокує індуковану гістаміном
шлункову секрецію, що є нетиповим, оскільки специфічні антигістамінні лікар=
ські
засоби не впливають на цей процес.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Також у дослідах на тваринах встановлено, що
ципрогептадин стимулює апетит.</span><span style=3D'font-size:12.0pt;font-f=
amily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-ansi-language:RU;mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Фармакокінетика.<o:p></o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Абсорбція<o:p></o:p></span></=
u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>При внутрішньому застосуванні ципрогептадин шв=
идко
і майже повністю всмоктується із шлунково-кишкового тракту. Максимальна
концентрація в плазмі крові досягається через <span
style=3D'mso-spacerun:yes'>     </span>4–8 годин після прийому лікарського
засобу. Тривалість дії – 4–6 годин, хоча плазмові рівні ципрогептадину
виявляються і через 24 години після прийому 4 мг ципрогептадину. Терапевтич=
ний
ефект ципрогептадину і його концентрація в плазмі крові не корелюють.<i><o:=
p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Метаболізм<o:p></o:p></span><=
/u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин інтенсивно метаболізується в
печінці. Головним метаболітом є глюкуроновий кон’югат четвертинного амонію
ципрогептадину. Він та інші метаболіти фармакологічно не активні.<i><o:p></=
o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Виведення<o:p></o:p></span></=
u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Після прийому 4 мг ципрогептадину одноразово 2=
–20
% прийнятої дози виводиться з калом, переважно у вигляді метаболітів, а 34 =
% —
у незміненому вигляді, що відповідає менш ніж 5,7&nbsp;% прийнятої дози.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Приблизно 40 % прийнятої дози ципрогептадину
виводиться з сечею. Майже 50 % ципрогептадину, який екскретується нирками,
виводяться у вигляді метаболітів протягом 3&nbsp;днів. Після повторного при=
йому
добової дози 12–20 мг в сечі можуть бути виявлені лише метаболіти
ципрогептадину. Період напіввиведення – 16 годин.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:0cm;margin-bottom=
:0cm;
margin-left:.95pt;margin-bottom:.0001pt;text-align:justify;line-height:norm=
al'><u><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Особливі гр=
упи
пацієнтів<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK'>Пацієнти з нирковою недостатніст=
ю</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK;mso-bidi-font-style:italic'>. </s=
pan><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>У пацієнтів=
 з
нирковою недостатністю екскреція ципрогептадину дещо знижується, тому таким
пацієнтам необхідно призначати менші дози.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:0cm;margin-bottom=
:0cm;
margin-left:.95pt;margin-bottom:.0001pt;text-align:justify;line-height:norm=
al'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-fareast-language:UK'>Пацієнти з печінковою недостатністю. </span></i><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>При
захворюваннях печінки необхідно призначати знижені дози, оскільки метаболізм
діючої речовини у таких пацієнтів відбувається повільніше.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:13.5pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Клінічні характеристики.</spa=
n></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Показання.</span></i></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:0cm;margin-right:0=
cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l1 lfo1'><![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:Symbol;mso-fareast-font-fam=
ily:
Symbol;mso-bidi-font-family:Symbol;mso-font-kerning:0pt;mso-fareast-languag=
e:
UK'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Алергічні захворювання, а сам=
е:
гостра та хронічна кропив’янка, ангіоневротичний набряк, медикаментозна
екзантема, свербіж, екзема, екзематозний дерматит, контактний дерматит,
нейродерміт, алергічний риніт, вазомоторний риніт, сироваткова хвороба та у=
куси
комах.<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l1 lfo1'><![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:Symbol;mso-fareast-font-fam=
ily:
Symbol;mso-bidi-font-family:Symbol;mso-font-kerning:0pt;mso-fareast-languag=
e:
UK'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Карциноїдний синдром
(симптоматичне лікування).<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l1 lfo1'><![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:Symbol;mso-fareast-font-fam=
ily:
Symbol;mso-bidi-font-family:Symbol;mso-font-kerning:0pt;mso-fareast-languag=
e:
UK'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Головний біль судинного
походження (лікування мігрені та гістамінової цефалгії).<o:p></o:p></span><=
/p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-top:0cm;margin-right:0c=
m;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l1 lfo1'><![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:Symbol;mso-fareast-font-fam=
ily:
Symbol;mso-bidi-font-family:Symbol;mso-font-kerning:0pt;mso-fareast-languag=
e:
UK'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Для підвищення апетиту та
загального стану у виснажених пацієнтів та пацієнтів із втратою апетиту з р=
ізних
причин (нервова анорексія, ідіопатична анорексія, стани після інфекційних
захворювань, хронічні захворювання, період реконвалесценції, виснаження).<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Протипоказання.</span></i></b=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:0cm;margin-right:0=
cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Підвищена
індивідуальна чутливість до діючої речовини, до інших фенотіазинів або до б=
удь-якого
іншого компонента лікарського засобу;<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>гострий нап=
ад
бронхіальної астми;<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>глаукома;<o=
:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>наявність
порушення евакуації шлунково-кишкового вмісту (стенозована пептична виразка,
пілоростеноз);<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>стани, що
супроводжуються затримкою сечі (симптоматична гіпертрофія передміхурової
залози, обструкція шийки сечового міхура);<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>одночасне
застосування інгібіторів моноаміноксидази (МАО);<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>протипоказа=
но пацієнтам
літнього віку та/або ослабленим пацієнтам;<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:0cm;margin-right:=
0cm;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>протипоказа=
но новонародженим
або недоношеним дітям;<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-top:0cm;margin-right:0c=
m;
margin-bottom:0cm;margin-left:14.2pt;margin-bottom:.0001pt;mso-add-space:au=
to;
text-align:justify;text-indent:-14.2pt;line-height:normal;mso-list:l14 leve=
l2 lfo1;
vertical-align:baseline'><![if !supportLists]><span lang=3DUK style=3D'font=
-size:
12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-font-kerning:0pt;mso-fareast-language:UK'><span style=3D'mso-lis=
t:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp; </span></span></span><![endif]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>період вагі=
тності
та годування груддю.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;vertical-align:baseline'><span lang=3DUK
style=3D'font-size:13.5pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Взаємодія з іншими лікарськими
засобами та інші види взаємодій.</span></i></b><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:"Times N=
ew Roman";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Інгібітори МАО можуть потенціювати та пролонгу=
вати
антихолінергічну дію антигістамінних лікарських засобів. Посилення седативн=
ої
дії може спостерігатися при сумісному застосуванні ципрогептадину з алкогол=
ем
та іншими речовинами, що пригнічують центральну нервову систему (седативні,
снодійні лікарські засоби, транквілізатори, анксіолітики). <o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Препарати з антисеротоніновою активністю, такі=
 як
ципрогептадин, можуть взаємодіяти з антидепресантами, що підвищують рівень
серотоніну, зокрема із селективними інгібіторами зворотного захоплення
серотоніну. Це може призвести до рецидиву депресії та пов’язаних із нею
симптомів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин може спричинити хибнопозитивний
результат дослідження сечі/плазми на наявність трициклічних антидепресантів=
. Оскільки
ципрогептадин та трициклічні антидепресанти можуть спричиняти подібні симпт=
оми
передозування, лікарям слід ретельно спостерігати за пацієнтами щодо токсич=
ності
трициклічних антидепресантів у разі комбінованого передозування.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Особливості застосування.</sp=
an></i></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Оскільки на початку лікування седативні ефекти
лікарського засобу проявляються частіше, рекомендується першу дозу лікарськ=
ого
засобу прийняти ввечері після останнього прийому їжі.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Антигістамінні лікарські засоби не слід
застосовувати для лікування захворювань нижніх дихальних шляхів, в тому чис=
лі
симптомів астми.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Антигістамінні лікарські засоби можуть знижува=
ти
розумову активність; однак у маленьких дітей вони іноді можуть спричиняти з=
будження.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Перитол<sup>®</sup> не рекомендується дітям до=
 2
років, оскільки його безпека та ефективність не встановлені в цій віковій
групі.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Передозування антигістамінних лікарських засоб=
ів,
особливо у дітей, може спричинити галюцинації, пригнічення центральної нерв=
ової
системи, судоми, зупинку дихання та серця і смерть.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Оскільки ципрогептадин проявляє антихолінергіч=
ні
ефекти, його слід з обережністю застосовувати пацієнтам із бронхіальною аст=
мою
в анамнезі, підвищеним внутрішньоочним тиском, гіпертиреозом, серцево-судин=
ними
захворюваннями, артеріальною гіпертензією. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Тривале лікування антигістамінними лікарськими
засобами може спричинити порушення з боку органів кровотворення (лейкопенія,
агранулоцитоз, тромбоцитопенія, гемолітична анемія). У разі появи пропасниц=
і,
фарингіту, уражень слизової оболонки щік (виразки у роті), блідості, жовтян=
иці,
гематом нез’ясованого походження або незвично сильної кровотечі необхідно
зробити аналіз крові. При виявленні порушень з боку органів кровотворення
необхідно припинити лікування.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Алкоголь може посилювати седативний вплив дано=
го
лікарського засобу на центральну нервову систему, тому під час лікування не
слід вживати алкогольні напої (див. розділ «Взаємодія з іншими лікарськими
засобами та інші види взаємодій»).<o:p></o:p></span></p>

<p class=3DMsoBodyTextIndent2 style=3D'margin:0cm;margin-bottom:.0001pt;tex=
t-align:
justify;line-height:normal;tab-stops:14.2pt'><span lang=3DUK style=3D'font-=
size:
12.0pt;font-family:"Times New Roman",serif'>Лікарський засіб </span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-language:
UK'>Перитол<sup>®<b><i> </i></b></sup></span><span lang=3DUK style=3D'font-=
size:
12.0pt;font-family:"Times New Roman",serif'>містить </span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-l=
anguage:
UK'>128 мг лактози</span><span lang=3DUK style=3D'font-size:12.0pt;font-fam=
ily:
"Times New Roman",serif'>, тому його не слід застосовувати пацієнтам, які м=
ають
спадкову непереносимість лактози, дефіцит лактази або синдром
глюкозо-галактозної мальабсорбції.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></i><=
/p>

<h2 style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify;line-heigh=
t:
normal'><i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New=
 Roman",serif;
color:windowtext;mso-font-kerning:0pt;mso-fareast-language:UK'>Застосування=
 у
період вагітності або годування груддю.<o:p></o:p></span></i></h2>

<h2 style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify;line-heigh=
t:
normal'><u><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New=
 Roman",serif;
color:windowtext;mso-font-kerning:0pt;mso-fareast-language:UK'>Вагітність<o=
:p></o:p></span></u></h2>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-farea=
st-language:
RU'>Немає достатнього клінічного досвіду застосування </span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>ципрогептад=
ину
у період вагітності</span><span lang=3DUK style=3D'font-size:12.0pt;font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-farea=
st-language:
RU'>. </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>Застосування лікарського засобу під час вагітності протипоказано.</span=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Годування груддю<o:p></o:p></=
span></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Невідомо, чи виділяється ципрогептадин у грудне
молоко, але оскільки він може спричинити потенційно серйозні побічні реакці=
ї у
немовлят, які перебувають на грудному вигодовуванні, застосування лікарсько=
го
засобу жінкам у період годування грудьми протипоказане. Потрібно прийняти
рішення щодо припинення грудного вигодовування або відміни ципрогептадину,
враховуючи важливість терапії для матері (див. розділ «Протипоказання»). <o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Здатність впливати на швидкіс=
ть
реакції при керуванні автотранспортом або іншими механізмами.</span></i><sp=
an
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин може викликати сонливість і
млявість. Тому пацієнтам, які його приймають, слід утриматися від керування
автотранспортом або роботи з механізмами.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Спосіб застосування та дози.<=
/span></i></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Лікування алергії та свербежу=
<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Доза&nbsp;лікарського засобу повинна визначати=
сь
індивідуально. Ефект від одноразової дози зазвичай триває від 4 до 6 годин.=
 Для
забезпечення тривалої ефективності добову дозу слід розділити на три прийом=
и або
застосовувати лікарський засіб з такою частотою, яка необхідна для підтрима=
ння
стійкого полегшення. Оскільки седативний ефект виникає частіше на початку
лікування, рекомендується першу дозу ципрогептадину прийняти ввечері після
останнього прийому їжі.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Дорослі<o:p></o:p></span></u>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Початкова добова доза може становити від 4 мг =
до 20
мг (1 таблетка 1–5 разів на добу); більшості пацієнтів потрібна доза 12–16 =
мг (1
таблетка 3–4 рази на добу). Рекомендована початкова добова доза — 12 мг (1
таблетка 3 рази на добу), потім дозу слід коригувати відповідно до маси тіл=
а та
реакції пацієнта на лікування. Максимальна добова доза — 32 мг (2&nbsp;табл=
етки
4 рази на добу). </span><span style=3D'font-size:12.0pt;font-family:"Times =
New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ansi-lan=
guage:
RU;mso-fareast-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:.7pt;margin-bottom:.0001pt;text-align:justify;line-height:norma=
l'><u><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Діти<o:p></=
o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Діти віком 7</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>–<i>14 рокі=
в:</i>
рекомендована добова доза становить 8–12 мг (1 таблетка 2–3 рази на добу) з=
алежно
від ваги пацієнта та відповіді на лікування. У разі необхідності можна прий=
няти
додаткову дозу на ніч. Максимальна добова доза — 16 мг (4 таблетки).<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Мігрень<o:p></o:p></span></u>=
</i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Початкова доза становить 4 мг (1&nbsp;таблетка)
одноразово. Якщо біль не зникає, через 30 хвилин прийняти ще 4 мг (1 таблет=
ку),
проте загальна доза лікарського засобу Перитол<sup>®</sup>, прийнята протяг=
ом
4–6 годин, не повинна перевищувати 8 мг (2 таблетки).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Для підтримуючого лікування зазвичай достатньо=
 12
мг (1 таблетка 3 рази на добу).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Особливі групи пацієнтів<o:p>=
</o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Пацієнти літнього віку та/або
ослаблені пацієнти<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Пацієнтам літнього віку та/або ослабленим
пацієнтам не слід приймати Перитол<sup>®</sup>, оскільки вони більш чутливі=
 до
можливих побічних ефектів антигістамінних лікарських засобів (запаморочення,
сонливість, гіпотензія).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-list:skip'><i style=3D'mso-bidi-font-style:n=
ormal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK'>Пацієнти з нирковою недостатніст=
ю</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK;mso-bidi-font-style:italic'><o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-list:skip'><span lang=3DUK style=3D'font-siz=
e:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-fareast-language:UK;mso-bidi-font-style:italic'>Для пацієнтів із нирков=
ою </span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>недостатніс=
тю</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK;mso-bidi-font-style:italic'> слід
проводити корекцію дози ципрогептадину та призначати меншу дозу, </span><sp=
an
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>оскільки ді=
юча
речовина значною мірою виводиться із сечею (</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:RU'>див. розділ
«Фармакокінетика»</span><span lang=3DUK style=3D'font-size:12.0pt;font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>). </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times =
New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:UK;mso-bidi-=
font-style:
italic'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-list:skip'><i style=3D'mso-bidi-font-style:n=
ormal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK'>Пацієнти з печінковою недостатні=
стю</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK;mso-bidi-font-style:italic'><o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal;mso-list:skip'><span lang=3DUK style=3D'font-siz=
e:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Слід призначати знижену дозу =
</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:UK;mso-bidi-font-style:italic'>ципро=
гептадину</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>, оскільки =
метаболізм
діючої речовини у пацієнтів із печінковою недостатністю знижується (</span>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:RU'>див. розділ
«Фармакокінетика»</span><span lang=3DUK style=3D'font-size:12.0pt;font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>). <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Спосіб застосування <o:p></o:=
p></span></u></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Лікарський засіб застосовувати перорально. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal=
'><b><i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;=
</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:.7pt;margin-bottom:.0001pt;text-align:justify;line-height:norma=
l'><i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;=
</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:.7pt;margin-bottom:.0001pt;text-align:justify;line-height:norma=
l'><i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;=
</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:.7pt;margin-bottom:.0001pt;text-align:justify;line-height:norma=
l'><i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;=
</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:2.9pt;margin-bott=
om:0cm;
margin-left:.7pt;margin-bottom:.0001pt;text-align:justify;line-height:norma=
l'><i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Діти</span>=
</i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Ципрогептадин не рекомендується дітям до 2 рок=
ів,
оскільки його безпека та ефективність не встановлені в цій віковій групі.</=
span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:RU'> У даній
лікарській формі препарат застосовують дітям віком від 7 років згідно з
рекомендаціями розділу «Спосіб застосування та дози».<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Передозування.<o:p></o:p></sp=
an></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Симптоми</span></i><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Випадкове або навмисне передозування
антигістамінних засобів може спричинити пригнічення центральної нервової
системи (седативний ефект, сонливість, кома) або викликати збудження і судо=
ми, зупинку
серця та дихання, що може призвести до летального наслідку, особливо у діте=
й.
Передозування ципрогептадину спричиняє антихолінергічні (атропіноподібні)
ефекти (сухість у роті, розширені зіниці, що не реагують на світло, приплив
крові до обличчя) та шлунково-кишкові розлади.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Лікування<o:p></o:p></span></=
i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>Якщо пацієнт притомний, то слід викликати блюв=
ання.
Якщо це неможливо, рекомендується промивання шлунка ізотонічним або
напівізотонічним розчином натрію хлориду та застосування активованого вугіл=
ля. Слід
вжити необхідних заходів, щоб уникнути аспірації, особливо у дітей. </span>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'>У =
разі
появи симптомів з боку центральної нервової системи, що загрожують життю, п=
отрібно
проводити відповідне симптоматичне лікування.</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> Можуть бути
ефективними сольові проносні засоби, які сприяють швидкій евакуації вмісту
кишечнику. </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Ti=
mes New Roman",serif'>Не
слід застосовувати стимулятори центральної нервової системи; у разі гіпотен=
зії
можна застосовувати вазопресорні засоби. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></i><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Побічні реакції.</span></i></=
b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif'>Під час застосування ципрогептадину часто виникає =
</span><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>в’ялість</s=
pan><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'> та
сонливість. На початку лікування ципрогептадином деякі пацієнти скаржилися =
на
сонливість, яка зазвичай зникала після 3–4 днів лікування.</span><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>При застосуванні лікарського засобу Перитол<su=
p>®<i>
</i></sup>можуть виникати такі побічні реакції.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку серцево-судинної систе=
ми: </span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>артеріальна
гіпотензія, пальпітація, тахікардія, екстрасистолія.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку крові та лімфатичної
системи: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"=
Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>гемолітична<i> </i>анемія, лейкопенія, агранулоцитоз, тромбоцитопенія.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку центральної нервової
системи:</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'> седативний ефект, сонливість (часто тимчасова), запаморочення, порушен=
ня
координації, тремор, парестезії, неврит, судоми, головний біль, слабкість, =
втрата
свідомості.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку психіки: </span></i><s=
pan
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>сплутаність
свідомості, неспокій, зорові галюцинації, збуджений стан, роздратованість, =
нервозність,
агресивна поведінка, безсоння, ейфорія, істерія.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'>З боку органів зору:</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'> н=
ечіткість
зору, </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>порушення акомодації (мідріаз), диплопія.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'>З боку органів слуху та рівноваги: </s=
pan></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'>го=
стрий<i>
</i></span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New=
 Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>лабіринтит, вертиго, шум у вухах.</span><i><span lang=3DUK style=3D'fon=
t-size:
12.0pt;font-family:"Times New Roman",serif'> </span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'><o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку імунної системи: </spa=
n></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>алергічний
набряк, анафілактичний шок.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку шкіри та підшкірних
тканин: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>еритема, пурпура, кропив’янка, рідко — набряк Квінке, гіпергідроз, виси=
пи, фоточутливість.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:RU;mso-bidi-font-weight:bold'>З боку
дихальної системи, органів грудної клітки та середостіння:</span></i><i><sp=
an
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> </span></i=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>сухість нос=
а та
горла, утворення густого бронхіального секрету, задишка, відчуття стиснення=
 у
грудях та хрипи</span><span lang=3DUK style=3D'font-size:12.0pt;font-family=
:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU;mso-bidi-=
font-weight:
bold'>, </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times=
 New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>закладеність носа, носові кровотечі. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку шлунково-кишкового тра=
кту:</span></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> сухість у =
ротовій
порожнині, нудота, блювання, дискомфорт в епігастрії, діарея, запор.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'>З боку гепатобіліарної системи:</span>=
</i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'> х=
олестаз,
гепатит, печінкова недостатність, порушення функції печінки, жовтяниця.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i style=3D'mso-bidi-font-style:normal'><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-fareast-language:RU;mso-bidi-font-weight:bold'>З боку
нирок та сечовивідних шляхів</span></i><i><span lang=3DUK style=3D'font-siz=
e:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>: </span></i><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>часті позив=
и до
сечовипускання, утруднення сечовипускання, затримка сечі.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>З боку</span></i><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> <i>репроду=
ктивної
системи та молочних залоз:</i> ранні менструації.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Порушення метаболізму і
харчування:</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family=
:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'> анорексія, підвищений апетит.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'>Загальні порушення та реакції у місці
введення</span></i><i><span lang=3DUK style=3D'font-size:12.0pt;font-family=
:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU;mso-bidi-=
font-weight:
bold'>: </span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU;mso-bidi-=
font-weight:
bold'>втома, </span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"=
Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-fareast-=
language:
UK'>озноб</span><i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU;mso-bidi-=
font-weight:
bold'>.</span></i><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Ti=
mes New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Результати досліджень: </span=
></i><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>збільшення =
маси
тіла.<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><u><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-fareast-language:RU;mso-bidi-font-weight:bold'>Повідомлення</span></u><=
u><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'> п=
ро
підозрювані побічні реакції<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-farea=
st-language:
RU;mso-bidi-font-weight:bold'>Повідомлення</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'> про побічні
реакції після реєстрації лікарського засобу має важливе значення. Це дає зм=
огу
проводити моніторинг співвідношення користь/ризик при застосуванні цього
лікарського засобу. Медичним та фармацевтичним працівникам, а також пацієнт=
ам
або їхнім законним представникам слід повідомляти про усі випадки підозрюва=
них
побічних реакцій та відсутності ефективності лікарського засобу через
Автоматизовану інформаційну систему з фармаконагляду за
посиланням:&nbsp;https://aisf.dec.gov.ua.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><i><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Термін придатності. </span></=
i></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>3 роки.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Умови зберігання. </span></b>=
<span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>Зберігати п=
ри
температурі не вище 25°С. Зберігати у недоступному для дітей місці.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Упаковка. </span></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>10 таблеток=
 у
блістері; по 2 блістери у картонній коробці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Категорія відпуску.</span></b=
><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'> За рецепто=
м.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-font-kerning:0pt;mso-fareast-language:UK'>Виробник. </span></b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-fareast-language:UK'>ЗАТ
Фармацевтичний завод ЕГІС, Угорщина.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'>Місцезнаходження виробника та адреса м=
ісця
провадження його діяльності.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><span lang=3DUK style=3D'font-size:12.0pt;font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-=
kerning:
0pt;mso-fareast-language:UK'>9900, м. Керменд, вул. Матяш кірай, 65, Угорщи=
на.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify;line-height:normal'><b><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:140.4pt'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;line-height:107%;font-family:"Times New Roman",serif'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:140.4pt'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;line-height:107%;font-family:"Times New Roman",serif'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:140.4pt'><span lang=3DUK style=3D'f=
ont-size:
12.0pt;line-height:107%;font-family:"Times New Roman",serif'><o:p>&nbsp;</o=
:p></span></p>

</div>

</body>

</html>

------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources xmln=
s:b=3D"http://schemas.openxmlformats.org/officeDocument/2006/bibliography" =
xmlns=3D"http://schemas.openxmlformats.org/officeDocument/2006/bibliography=
" SelectedStyle=3D"\APASixthEditionOfficeOnline.xsl" StyleName=3D"APA" Vers=
ion=3D"6"></b:Sources>
------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{776871AB-CA2D-4AAA-AF39-16C162DEBCC0}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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==

------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../UA90350101_45F1.htm">
<![if IE]>
<base href=3D"file:///C:/680ADCF1/UA90350101_45F1.files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]-->
</head>

<body lang=3DRU link=3D"#467886" vlink=3D"#96607D">

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-separ=
ator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-conti=
nuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-separ=
ator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-=
height:
normal'><span lang=3DUK><span style=3D'mso-special-character:footnote-conti=
nuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dright style=3D'margin-top:12.0pt;text-align:ri=
ght'><!--[if supportFields]><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'><s=
pan
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>  
</span>\* MERGEFORMAT<span style=3D'mso-element:field-separator'></span></s=
pan><![endif]--><span
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif;mso-ansi-lang=
uage:
RU;mso-no-proof:yes'>1</span><!--[if supportFields]><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'><span
style=3D'mso-element:field-end'></span></span><![endif]--><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman",serif'><o:p></o:p><=
/span></p>

</div>

</body>

</html>

------=_NextPart_01DD78F8.83A6EB80
Content-Location: file:///C:/680ADCF1/UA90350101_45F1.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA90350101_45F1.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01DD78F8.83A6EB80--
